Literature DB >> 34762139

DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.

Marie Cuvellier1, Frédéric Ezan1, Georges Baffet2, Sophie Langouët3, Sophie Rose1, Jennifer Carteret1, Arnaud Bruyère1, Vincent Legagneux1, Fabrice Nesslany4.   

Abstract

The liver is essential in the elimination of environmental and food contaminants. Given the interspecies differences between rodents and humans, the development of relevant in vitro human models is crucial to investigate liver functions and toxicity in cells that better reflect pathophysiological processes. Classically, the differentiation of the hepatic HepaRG cell line requires high concentration of dimethyl sulfoxide (DMSO), which restricts its usefulness for drug-metabolism studies. Herein, we describe undifferentiated HepaRG cells embedded in a collagen matrix in DMSO-free conditions that rapidly organize into polarized hollow spheroids of differentiated hepatocyte-like cells (Hepoid-HepaRG). Our conditions allow concomitant proliferation with high levels of liver-specific functions and xenobiotic metabolism enzymes expression and activities after a few days of culture and for at least 4 weeks. By studying the toxicity of well-known injury-inducing drugs by treating cells with 1- to 100-fold of their plasmatic concentrations, we showed appropriate responses and demonstrate the sensitivity to drugs known to induce various degrees of liver injury. Our results also demonstrated that the model is well suited to estimate cholestasis and steatosis effects of drugs following chronic treatment. Additionally, DNA alterations caused by four genotoxic compounds (Aflatoxin B1 (AFB1), Benzo[a]Pyrene (B[a]P), Cyclophosphamide (CPA) and Methyl methanesulfonate (MMS)) were quantified in a dose-dependent manner by the comet and micronucleus assays. Their genotoxic effects were significantly increased after either an acute 24 h treatment (AFB1: 1.5-6 μM, CPA: 2.5-10 μM, B[a]P: 12.5-50 μM, MMS: 90-450 μM) or after a 14-day treatment at much lower concentrations (AFB1: 0.05-0.2 μM, CPA: 0.125-0.5 μM, B[a]P: 0.125-0.5 μM) representative to human exposure. Altogether, the DMSO-free 3D culture of Hepoid-HepaRG provides highly differentiated and proliferating cells relevant for various toxicological in vitro assays, especially for drug-preclinical studies and environmental chemicals risk assessment.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  3D culture model; Genotoxicity; HepaRG cells; Human liver injury; Long-term differentiation; Toxicity screening

Mesh:

Substances:

Year:  2021        PMID: 34762139     DOI: 10.1007/s00204-021-03178-x

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  43 in total

1.  Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.

Authors:  Caroline Aninat; Amélie Piton; Denise Glaise; Typhen Le Charpentier; Sophie Langouët; Fabrice Morel; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Drug Metab Dispos       Date:  2005-10-04       Impact factor: 3.922

2.  Maintenance of High Cytochrome P450 Expression in HepaRG Cell Spheroids in DMSO-Free Medium.

Authors:  A V Aleksandrova; O A Burmistrova; K A Fomicheva; D A Sakharov
Journal:  Bull Exp Biol Med       Date:  2016-06-06       Impact factor: 0.804

Review 3.  Case definition and phenotype standardization in drug-induced liver injury.

Authors:  G P Aithal; P B Watkins; R J Andrade; D Larrey; M Molokhia; H Takikawa; C M Hunt; R A Wilke; M Avigan; N Kaplowitz; E Bjornsson; A K Daly
Journal:  Clin Pharmacol Ther       Date:  2011-05-04       Impact factor: 6.875

4.  Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.

Authors:  Sagnik Chatterjee; Lysiane Richert; Patrick Augustijns; Pieter Annaert
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

5.  Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.

Authors:  Sébastien Anthérieu; Christophe Chesné; Ruoya Li; Sandrine Camus; Agustin Lahoz; Laura Picazo; Miia Turpeinen; Ari Tolonen; Jouko Uusitalo; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Drug Metab Dispos       Date:  2009-12-17       Impact factor: 3.922

6.  Increasing 3D Matrix Rigidity Strengthens Proliferation and Spheroid Development of Human Liver Cells in a Constant Growth Factor Environment.

Authors:  Jérémy Bomo; Frédéric Ezan; François Tiaho; Medjda Bellamri; Sophie Langouët; Nathalie Theret; Georges Baffet
Journal:  J Cell Biochem       Date:  2015-09-08       Impact factor: 4.429

7.  3D culture of HepaRG cells in GelMa and its application to bioprinting of a multicellular hepatic model.

Authors:  Marie Cuvellier; Frédéric Ezan; Hugo Oliveira; Sophie Rose; Jean-Christophe Fricain; Sophie Langouët; Vincent Legagneux; Georges Baffet
Journal:  Biomaterials       Date:  2020-12-16       Impact factor: 12.479

8.  Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo.

Authors:  Simon Bucher; Arnaud Tête; Normand Podechard; Marie Liamin; Dounia Le Guillou; Martine Chevanne; Cédric Coulouarn; Muhammad Imran; Isabelle Gallais; Morgane Fernier; Quentin Hamdaoui; Marie-Anne Robin; Odile Sergent; Bernard Fromenty; Dominique Lagadic-Gossmann
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

9.  Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.

Authors:  Catherine C Bell; Delilah F G Hendriks; Sabrina M L Moro; Ewa Ellis; Joanne Walsh; Anna Renblom; Lisa Fredriksson Puigvert; Anita C A Dankers; Frank Jacobs; Jan Snoeys; Rowena L Sison-Young; Rosalind E Jenkins; Åsa Nordling; Souren Mkrtchian; B Kevin Park; Neil R Kitteringham; Christopher E P Goldring; Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

10.  Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.

Authors:  Gillian E Conway; Ume-Kulsoom Shah; Samantha Llewellyn; Tereza Cervena; Stephen J Evans; Abdullah S Al Ali; Gareth J Jenkins; Martin J D Clift; Shareen H Doak
Journal:  Mutagenesis       Date:  2020-09-12       Impact factor: 3.000

View more
  4 in total

1.  Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells.

Authors:  Audrey Barranger; Ludovic Le Hégarat
Journal:  Arch Toxicol       Date:  2022-04-13       Impact factor: 6.168

Review 2.  Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Authors:  Christopher D Kassotis; Frederick S Vom Saal; Patrick J Babin; Dominique Lagadic-Gossmann; Helene Le Mentec; Bruce Blumberg; Nicole Mohajer; Antoine Legrand; Vesna Munic Kos; Corinne Martin-Chouly; Normand Podechard; Sophie Langouët; Charbel Touma; Robert Barouki; Min Ji Kim; Karine Audouze; Mahua Choudhury; Nitya Shree; Amita Bansal; Sarah Howard; Jerrold J Heindel
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

3.  A Preliminary Investigation of Embedding In Vitro HepaRG Spheroids into Recombinant Human Collagen Type I for the Promotion of Liver Differentiation.

Authors:  Fang-Chun Liao; Yang-Kao Wang; Ming-Yang Cheng; Ting-Yuan Tu
Journal:  Polymers (Basel)       Date:  2022-05-09       Impact factor: 4.967

Review 4.  In Vitro Models for Studying Chronic Drug-Induced Liver Injury.

Authors:  M Teresa Donato; Gloria Gallego-Ferrer; Laia Tolosa
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.